Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPfizer Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 13 | $0.67 | $0.76 | $0.72 |
| Q2 2026 | 12 | $0.66 | $0.72 | $0.68 |
| Q3 2026 | 11 | $0.81 | $0.89 | $0.85 |
| Q4 2026 | 9 | $0.65 | $0.71 | $0.69 |
| Q1 2027 | 4 | $0.59 | $0.65 | $0.63 |
| Q2 2027 | 4 | $0.59 | $0.65 | $0.63 |
| Q3 2027 | 7 | $0.76 | $0.84 | $0.81 |
| Q4 2027 | 4 | $0.55 | $0.60 | $0.58 |
Pfizer Inc. Earnings Date And Information
Pfizer Inc. last posted its earnings results on Tuesday, May 5th, 2026. The company reported $0.75 earnings per share for the quarter, topping analysts' consensus estimates of $0.722 by $0.028. The company had revenue of 14.45 B for the quarter and had revenue of 62.58 B for the year. Pfizer Inc. has generated $1 earnings per share over the last year ($1.36 diluted earnings per share) and currently has a price-to-earnings ratio of 19.15. Pfizer Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Pfizer Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/05/2026 | Q1 2026 | $0.72 | $0.47 | -0.25 | $13.84 B | $14.45 B |
| 02/26/2026 | Q4 2025 | N/A | -$0.29 | N/A | N/A | $17.56 B |
| 11/04/2025 | Q3 2025 | $0.63 | $0.62 | -0.01 | N/A | $16.65 B |
| 08/05/2025 | Q2 2025 | $0.58 | $0.51 | -0.07 | $13.56 B | $14.65 B |
| 05/05/2025 | Q1 2025 | N/A | $0.52 | N/A | N/A | $13.72 B |
| 02/27/2025 | Q4 2024 | N/A | $0.07 | N/A | N/A | $17.76 B |
| 11/04/2024 | Q3 2024 | N/A | $0.79 | N/A | $14.92 B | $17.70 B |
| 08/05/2024 | Q2 2024 | N/A | $0.00 | N/A | N/A | $13.28 B |
| 05/08/2024 | Q1 2024 | N/A | $0.55 | N/A | $13.87 B | $14.88 B |
| 02/22/2024 | Q4 2023 | N/A | -$0.60 | N/A | N/A | $14.57 B |
| 11/08/2023 | Q3 2023 | N/A | -$0.42 | N/A | N/A | $13.49 B |
| 08/09/2023 | Q2 2023 | N/A | $0.41 | N/A | N/A | $13.01 B |
| 05/10/2023 | Q1 2023 | N/A | $0.98 | N/A | N/A | $18.49 B |
| 02/23/2023 | Q4 2022 | N/A | $0.89 | N/A | N/A | $24.29 B |
| 11/09/2022 | Q3 2022 | N/A | $1.54 | N/A | N/A | $22.64 B |
| 08/10/2022 | Q2 2022 | N/A | $1.77 | N/A | N/A | $27.74 B |
| 05/11/2022 | Q1 2022 | N/A | $1.40 | N/A | N/A | $25.66 B |
| 02/24/2022 | Q4 2021 | N/A | $0.60 | N/A | N/A | $23.84 B |
| 11/12/2021 | Q3 2021 | N/A | $1.45 | N/A | N/A | $24.04 B |
| 08/12/2021 | Q2 2021 | N/A | $1.04 | N/A | N/A | $18.90 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Pfizer Inc. Earnings: FAQ's
In the previous quarter, Pfizer Inc. (:PFE) reported $0.75 earnings per share (EPS) to beat the analysts' consensus estimate of $0.722 by $0.028.
The conference call for Pfizer Inc.'s latest earnings report can be listened to online.
The conference call transcript for Pfizer Inc.'s latest earnings report can be read online.
Pfizer Inc. (:PFE) has a recorded annual revenue of $62.58 B.
Pfizer Inc. (:PFE) has a recorded net income of $7.77 B.Pfizer Inc. has generated $1.36 earnings per share over the last four quarters.
Pfizer Inc. (:PFE) has a price-to-earnings ratio of 19.15 and price/earnings-to-growth ratio is -3.33.